Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Nicholas Doerr"'
Autor:
Nicholas Doerr, Yidi Wang, Kevin R Kipp, Guangyi Liu, Jesse J Benza, Vladimir Pletnev, Tengis S Pavlov, Alexander Staruschenko, Ashraf M Mohieldin, Maki Takahashi, Surya M Nauli, Thomas Weimbs
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0161525 (2016)
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a common genetic disease that leads to progressive renal cyst growth and loss of renal function, and is caused by mutations in the genes encoding polycystin-1 (PC1) and polycystin-2 (PC2), respe
Externí odkaz:
https://doaj.org/article/2dd1bd64898141e3a8683112f025fee9
Autor:
Masaw Akbari, Jonathan D. West, Nicholas Doerr, Kevin R. Kipp, Neda Marhamati, Sabrina Vuong, Yidi Wang, Markus M. Rinschen, Jeffrey J. Talbot, Oliver Wessely, Thomas Weimbs
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, vol 119, iss 30
Akbari, M, West, J D, Doerr, N, Kipp, K R, Marhamati, N, Vuong, S, Wang, Y, Rinschen, M M, Talbot, J J, Wessely, O & Weimbs, T 2022, ' Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression ', Proceedings of the National Academy of Sciences of the United States of America, vol. 119, no. 30, e2121267119 . https://doi.org/10.1073/pnas.2121267119
Akbari, M, West, J D, Doerr, N, Kipp, K R, Marhamati, N, Vuong, S, Wang, Y, Rinschen, M M, Talbot, J J, Wessely, O & Weimbs, T 2022, ' Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression ', Proceedings of the National Academy of Sciences of the United States of America, vol. 119, no. 30, e2121267119 . https://doi.org/10.1073/pnas.2121267119
Autosomal dominant polycystic kidney disease (ADPKD) affects more than 500,000 individuals in the United States alone. In most cases, ADPKD is caused by a loss-of-function mutation in the PKD1 gene, which encodes polycystin-1 (PC1). Previous studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f72725d05c6f86d382499b53f3482e3
https://escholarship.org/uc/item/0rw4q0ck
https://escholarship.org/uc/item/0rw4q0ck
Publikováno v:
American Journal of Physiology-Renal Physiology. 315:F86-F96
Autosomal dominant polycystic kidney disease (ADPKD) is a life-threatening, highly prevalent monogenic disease caused by mutations in polycystin-1 (PC1) in 85% of patients. We have previously identified a COOH-terminal cleavage fragment of PC1, PC1-p
Autor:
Nicholas Doerr, Florian Bernet, Thomas Weimbs, Justyna Iwaszkiewicz, Séverine Urfer, Lucia Carolina Leal-Esteban, Daniel B. Constam, Benjamin Rothé
Publikováno v:
Molecular and Cellular Biology
Molecular and cellular biology, vol 35, iss 19
Molecular and cellular biology, vol 35, iss 19
Loss of the RNA-binding protein Bicaudal-C (Bicc1) provokes renal and pancreatic cysts as well as ectopic Wnt/beta-catenin signaling during visceral left-right patterning. Renal cysts are linked to defective silencing of Bicc1 target mRNAs, including
Autor:
Xiaofang Wang, Jeffrey J. Talbot, Bernhard Schermer, Xuewen Song, York Pei, Vicente E. Torres, Nicholas Doerr, Thomas Weimbs, Markus M. Rinschen, Wells B. LaRiviere
Publikováno v:
Talbot, J J, Song, X, Wang, X, Rinschen, M M, Doerr, N, La Riviere, W B, Schermer, B, Pei, Y P, Torres, V E & Weimbs, T 2014, ' The cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation ', Journal of the American Society of Nephrology, vol. 25, no. 8, pp. 1737-1748 . https://doi.org/10.1681/ASN.2013091026
Polycystin-1 (PC1) mutations result in proliferative renal cyst growth and progression to renal failure in autosomal dominant polycystic kidney disease (ADPKD). The transcription factor STAT3 (signal transducer and activator of transcription 3) was s
Autor:
Guangyi Liu, Maki Takahashi, Jesse J. Benza, Ashraf M. Mohieldin, Surya M. Nauli, Kevin R. Kipp, Tengis S. Pavlov, Nicholas Doerr, Thomas Weimbs, Vladimir Z. Pletnev, Yidi Wang, Alexander Staruschenko
Publikováno v:
PloS one, vol 11, iss 8
PLoS ONE
PLoS ONE, Vol 11, Iss 8, p e0161525 (2016)
PLoS ONE
PLoS ONE, Vol 11, Iss 8, p e0161525 (2016)
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a common genetic disease that leads to progressive renal cyst growth and loss of renal function, and is caused by mutations in the genes encoding polycystin-1 (PC1) and polycystin-2 (PC2), respe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c3ba13798c5599980be5f04b0d3c0de
https://escholarship.org/uc/item/7pn0w1cg
https://escholarship.org/uc/item/7pn0w1cg
Autor:
Shaun Flynn, James Bready, Shawn Harriman, Vinod F. Patel, Zhiyang Zhao, Alexander M. Long, Anthony Polverino, Jean-Christophe Harmange, Michael Morrison, Jay Larrow, Nicholas Doerr, Daniel S. La, Juan Estrada, Thomas DeMelfi, Julie Belzile, Matthew Weiss, Julie Flynn, Yohannes Teffera, Douglas A. Whittington, Russell Graceffa, Philip Roveto, Matthew W. Martin, Angela Coxon, Ling Wang
Publikováno v:
Journal of Medicinal Chemistry. 51:1695-1705
Angiogenesis is vital for solid tumor growth, and its prevention is a proven strategy for the treatment of disease states such as cancer. The vascular endothelial growth factor (VEGF) pathway provides several opportunities by which small molecules ca
Autor:
Anthony Polverino, Yan Gu, Roger Zanon, Lucian DiPietro, Joseph L. Kim, Michele Potashman, Paul E. Rose, Juan Estrada, Thomas DeMelfi, Paul Gallant, Rick Kendall, Angela Coxon, Douglas A. Whittington, Stephen Kaufman, Alexander M. Long, Nicholas Doerr, Huilin Zhao, Gondi N. Kumar, Simon Van Der Plas, Julie Germain, Daniel Elbaum, Jean-Christophe Harmange, Vinod F. Patel, Seshadri Neervannan, James Bready
Publikováno v:
Journal of Medicinal Chemistry. 50:4351-4373
Inhibition of the VEGF signaling pathway has become a valuable approach in the treatment of cancers. Guided by X-ray crystallography and molecular modeling, a series of 2-aminobenzimidazoles and 2-aminobenzoxazoles were identified as potent inhibitor
Autor:
Matthew W. Martin, Ryan White, Daniel S. La, Matthew Weiss, Anthony Polverino, Andrew Tasker, Lucian DiPietro, Sesha Neervannan, Stephen Kaufman, Roger Zanon, Deborah Choquette, Jean-Christophe Harmange, Juan Estrada, Ling Wang, Kelly Regal, Michele Potashman, Danlin Chen, Tom DeMelfi, Angela Coxon, Nicholas Doerr, Vinod F. Patel, Russell Graceffa, Douglas A. Whittington, Julie Flynn, Shawn Harriman, Alexander M. Long, Charlie Starnes, George Borg, Michael Schrag, Julie Germain, Philip Roveto, Yohannes Teffera, James Bready
Publikováno v:
Journal of medicinal chemistry. 51(6)
A series of naphthyl-based compounds were synthesized as potential inhibitors of vascular endothelial growth factor (VEGF) receptors. Investigations of structure–activity relationships led to the identification of a series of naphthamides that are
Autor:
Kurt Redlich, George Kollias, Helga Bergmeister, Günter Steiner, Paul J. Kostenuik, Silvia Hayer, Nicholas Doerr, Georg Schett, Jochen Zwerina, Josef S. Smolen, Birgit Görtz
Publikováno v:
The American journal of pathology. 164(2)
Local bone erosion and systemic bone loss are hallmarks of rheumatoid arthritis and cause progressive disability. Tumor necrosis factor (TNF) is a key mediator of arthritis and acts catabolically on bone by stimulating bone resorption and inhibiting